Targeting IAP expression has been shown to sensitize cancer cells to TRAIL-induced cell death [89,90], suggesting that in cancer cells whose IAP is overexpressed, inhibition of IAP is a strategy to overcome resistance to TRAIL. This evidence concerns the gene TNFSF10 and cancer.